Cargando…
A review of fibrin and fibrin composites for bone tissue engineering
Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as pol...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516781/ https://www.ncbi.nlm.nih.gov/pubmed/28761338 http://dx.doi.org/10.2147/IJN.S124671 |
_version_ | 1783251226531463168 |
---|---|
author | Noori, Alireza Ashrafi, Seyed Jamal Vaez-Ghaemi, Roza Hatamian-Zaremi, Ashraf Webster, Thomas J |
author_facet | Noori, Alireza Ashrafi, Seyed Jamal Vaez-Ghaemi, Roza Hatamian-Zaremi, Ashraf Webster, Thomas J |
author_sort | Noori, Alireza |
collection | PubMed |
description | Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as polymers or hydrogels), there has been a lot of excitement surrounding the use of natural materials due to their biologically inspired properties. Fibrin is a natural scaffold formed following tissue injury that initiates hemostasis and provides the initial matrix useful for cell adhesion, migration, proliferation, and differentiation. Fibrin has captured the interest of bone tissue engineers due to its excellent biocompatibility, controllable biodegradability, and ability to deliver cells and biomolecules. Fibrin is particularly appealing because its precursors, fibrinogen, and thrombin, which can be derived from the patient’s own blood, enable the fabrication of completely autologous scaffolds. In this article, we highlight the unique properties of fibrin as a scaffolding material to treat bone defects. Moreover, we emphasize its role in bone tissue engineering nanocomposites where approaches further emulate the natural nanostructured features of bone when using fibrin and other nanomaterials. We also review the preparation methods of fibrin glue and then discuss a wide range of fibrin applications in bone tissue engineering. These include the delivery of cells and/or biomolecules to a defect site, distributing cells, and/or growth factors throughout other pre-formed scaffolds and enhancing the physical as well as biological properties of other biomaterials. Thoughts on the future direction of fibrin research for bone tissue engineering are also presented. In the future, the development of fibrin precursors as recombinant proteins will solve problems associated with using multiple or single-donor fibrin glue, and the combination of nanomaterials that allow for the incorporation of biomolecules with fibrin will significantly improve the efficacy of fibrin for numerous bone tissue engineering applications. |
format | Online Article Text |
id | pubmed-5516781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55167812017-07-31 A review of fibrin and fibrin composites for bone tissue engineering Noori, Alireza Ashrafi, Seyed Jamal Vaez-Ghaemi, Roza Hatamian-Zaremi, Ashraf Webster, Thomas J Int J Nanomedicine Review Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as polymers or hydrogels), there has been a lot of excitement surrounding the use of natural materials due to their biologically inspired properties. Fibrin is a natural scaffold formed following tissue injury that initiates hemostasis and provides the initial matrix useful for cell adhesion, migration, proliferation, and differentiation. Fibrin has captured the interest of bone tissue engineers due to its excellent biocompatibility, controllable biodegradability, and ability to deliver cells and biomolecules. Fibrin is particularly appealing because its precursors, fibrinogen, and thrombin, which can be derived from the patient’s own blood, enable the fabrication of completely autologous scaffolds. In this article, we highlight the unique properties of fibrin as a scaffolding material to treat bone defects. Moreover, we emphasize its role in bone tissue engineering nanocomposites where approaches further emulate the natural nanostructured features of bone when using fibrin and other nanomaterials. We also review the preparation methods of fibrin glue and then discuss a wide range of fibrin applications in bone tissue engineering. These include the delivery of cells and/or biomolecules to a defect site, distributing cells, and/or growth factors throughout other pre-formed scaffolds and enhancing the physical as well as biological properties of other biomaterials. Thoughts on the future direction of fibrin research for bone tissue engineering are also presented. In the future, the development of fibrin precursors as recombinant proteins will solve problems associated with using multiple or single-donor fibrin glue, and the combination of nanomaterials that allow for the incorporation of biomolecules with fibrin will significantly improve the efficacy of fibrin for numerous bone tissue engineering applications. Dove Medical Press 2017-07-12 /pmc/articles/PMC5516781/ /pubmed/28761338 http://dx.doi.org/10.2147/IJN.S124671 Text en © 2017 Noori et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Noori, Alireza Ashrafi, Seyed Jamal Vaez-Ghaemi, Roza Hatamian-Zaremi, Ashraf Webster, Thomas J A review of fibrin and fibrin composites for bone tissue engineering |
title | A review of fibrin and fibrin composites for bone tissue engineering |
title_full | A review of fibrin and fibrin composites for bone tissue engineering |
title_fullStr | A review of fibrin and fibrin composites for bone tissue engineering |
title_full_unstemmed | A review of fibrin and fibrin composites for bone tissue engineering |
title_short | A review of fibrin and fibrin composites for bone tissue engineering |
title_sort | review of fibrin and fibrin composites for bone tissue engineering |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516781/ https://www.ncbi.nlm.nih.gov/pubmed/28761338 http://dx.doi.org/10.2147/IJN.S124671 |
work_keys_str_mv | AT noorialireza areviewoffibrinandfibrincompositesforbonetissueengineering AT ashrafiseyedjamal areviewoffibrinandfibrincompositesforbonetissueengineering AT vaezghaemiroza areviewoffibrinandfibrincompositesforbonetissueengineering AT hatamianzaremiashraf areviewoffibrinandfibrincompositesforbonetissueengineering AT websterthomasj areviewoffibrinandfibrincompositesforbonetissueengineering AT noorialireza reviewoffibrinandfibrincompositesforbonetissueengineering AT ashrafiseyedjamal reviewoffibrinandfibrincompositesforbonetissueengineering AT vaezghaemiroza reviewoffibrinandfibrincompositesforbonetissueengineering AT hatamianzaremiashraf reviewoffibrinandfibrincompositesforbonetissueengineering AT websterthomasj reviewoffibrinandfibrincompositesforbonetissueengineering |